Tag: Antheia

Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year

Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year

Advanced biosynthesis company will accelerate commercialization of critical pharmaceutical ingredients and establish U.S. manufacturing operations MENLO PARK, Calif., Jan. 27, 2026 /PRNewswire/ — Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced it has…

Read More Read More

Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy

Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy

New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform MENLO PARK, Calif., June 3, 2025 /PRNewswire/ — Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains,…

Read More Read More